期刊文献+

药物经济学评价中敏感度分析的参数分布 被引量:24

Distributions for parameters in sensitivity analysis of phamacoeconomics evaluation
原文传递
导出
摘要 目的旨在探讨当进行药物经济学评价时,如何在敏感度分析中选择合适的参数分布。方法针对各种类型参数,根据其限定条件,结合分布特征,选择合适的参数分布假设。结果概率参数只能在0到1之间取值,互斥时间概率的总和应等于1;相对风险参数的可信区间是通过对数转换所得;成本参数取值范围为0至无穷大;效用参数通常取值0至1(特殊情况低于0)。结论概率参数可假设为Beta分布,相对风险参数可假设为对数正态分布,成本参数可假设为伽马分布或对数正态分布,效用参数可假设为Beta分布、对数正态分布或伽马分布。 AIM To investigate how to choose and fit parameter distributions in sensitivity analysis of pharmacoeconomics evaluation. METHODS According to the limited conditions of all kinds of parameters and combined with the feature of distribution, the appropriate parameter distribution hypotheses were chosen. RESULTS Probability parameters had an important constraint that all probabilities can only take values in the range from zero to one. Furthermore, probabilities of mutually exclusive events must sum to one. The confidence interval of relative risk parameters was calculated on the log scale. Cost data was constrained to be non-negative. Utility parameters usually ranged between zero and one (lower than zero in particular cases). CONCLUSION The beta distribution fits the probability parameters. The appropriate distributional assumption of relative risk parameters is lognormal. The appropriate distributional assumptions of cost data are gamma or lognormal. The appropriate distributional assumptions of utilities parameters are beta, lognormal or gamma.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2015年第12期961-964,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家自然科学基金(81173028) 青年科学基金项目(81401547)
关键词 经济学 药学 概率 二项分布 正态分布 economics, pharmaceutical probability binomial distribution normal distribution
  • 相关文献

参考文献12

  • 1徐端正.药物经济学及其分析[J].中国新药与临床杂志,2000,19(2):139-142. 被引量:487
  • 2BRIGGS AH, GRAY AM. Handing unce~tainty in economic evaluations of healthcare interventions[J]. B M J, 1999,319 ( 721 O) : 635-638.
  • 3BRIGGS AH. Handing uncertainty in cost-effectiveness models [J]. Pharmacoeconomics, 2000, 17(5) : 479-500.
  • 4<中国药物经济学评价指南>课题组,刘国恩,胡善联,吴久鸿.中国药物经济学评价指南(2011版)[J].中国药物经济学,2011(3):6-48. 被引量:286
  • 5TAN CQ, PENG LB, ZENG XH, et al. Economic evaluation of first-line adjuvant chemotherapies for reseetable gastric cancer patients in China[J]. PLoS One, 2013, 8(12): c83396.
  • 6TAN CQ, PENG LB, ZENG XH, et al. Cost-utility analysis of the new]y recommended adjuvant chemotherapy ~)~r resectable gastric cancer patients in the 2011 Chinese national comprehensive cancer network (NCCN) clinical practice guidelines in oncology: gastric cancer[J]. Pharmaco Economics, 2014, 32(3): 235-243.
  • 7赵林.Beta分布与其他分布关系及其应用[J].安徽建筑工业学院学报(自然科学版),2008,16(2):80-81. 被引量:3
  • 8CHANCELLOR JV, HILL AM, SABIN CA, et al. Modelling the cost effectiveness of lamivudine/zidowudine combination therapy in HIV infection[J]. Pharmaeo Economies, 1997, 12(1 ): 54-66.
  • 9于洋,孙月静.对数正态分布参数的最大似然估计[J].九江学院学报(社会科学版),2007,26(6):55-57. 被引量:15
  • 10ANDREW BRIGGS, KAL CLAXTON, MARK SCULPHER. Decision modeling for health economic evaluation[M]. United State: Oxford University Press Inc., 2006: 84.

二级参考文献76

共引文献782

同被引文献224

引证文献24

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部